Trial Profile
A phase I/II study of docetaxel plus prednisolone plus diethylstilbestrol plus aspirin in androgen-independent prostate cancer
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 18 Jun 2019
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Aspirin; Diethylstilbestrol; Prednisolone
- Indications Adenocarcinoma; Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 25 Oct 2005 New trial record.